» Articles » PMID: 39060155

Prevalence and Neurological Outcomes of Comatose Patients With Extracorporeal Membrane Oxygenation

Abstract

Objectives: To investigate prevalence, risk factors, and in-hospital outcomes of comatose extracorporeal membrane oxygenation (ECMO) patients.

Design: Retrospective observational.

Setting: Tertiary academic hospital.

Participants: Adults received venoarterial (VA) or venovenous (VV) ECMO support between November 2017 and April 022.

Interventions: None.

Measurements And Main Results: We defined 24-hour off sedation as no sedative infusion (except dexmedetomidine) or paralytics administration over a continuous 24-hour period while on ECMO. Off-sedation coma (coma) was defined as a Glasgow Coma Scale score of ≤8 after achieving 24-hour off sedation. On-sedation coma (coma) was defined as a Glasgow Coma Scale score of ≤8 during the entire ECMO course without off sedation for 24 hours. Neurological outcomes were assessed at discharge using the modified Rankin scale (good, 0-3; poor, 4-6). We included 230 patients (VA-ECMO 143, 65% male); 24-hour off sedation was achieved in 32.2% VA-ECMO and 26.4% VV-ECMO patients. Among all patients off sedation for 24 hours (n = 69), 56.5% VA-ECMO and 52.2% VV-ECMO patients experienced coma. Among those unable to be sedation free for 24 hours (n = 161), 50.5% VA-ECMO and 17.2% VV-ECMO had coma. Coma was associated with poor outcomes (p < 0.05) in VA-ECMO and VV-ECMO groups, whereas coma only impacted the VA-ECMO group outcomes. In a multivariable analysis, requirement of renal replacement therapy was an independent risk factor for coma after adjusting for ECMO configuration, after adjusting for ECMO configuration, acute brain injury, pre-ECMO partial pressure of oxygen in arterial blood, partial pressure of carbon dioxide in arterial blood, pH, and bicarbonate level (worst value within 24 hours before cannulation).

Conclusions: Coma was common and associated with poor outcomes at discharge. Requirement of renal replacement therapy was an independent risk factor.

References
1.
Caturegli G, Cho S, White B, Chen L . Acute Brain Injury in Infant Venoarterial Extracorporeal Membrane Oxygenation: An Autopsy Study. Pediatr Crit Care Med. 2020; 22(3):297-302. DOI: 10.1097/PCC.0000000000002573. View

2.
Greer D, Shemie S, Lewis A, Torrance S, Varelas P, Goldenberg F . Determination of Brain Death/Death by Neurologic Criteria: The World Brain Death Project. JAMA. 2020; 324(11):1078-1097. DOI: 10.1001/jama.2020.11586. View

3.
Galante O, Hasidim A, Almog Y, Cohen A, Makhoul M, Soroksky A . Extracorporal Membrane Oxygenation in Nonintubated Patients (Awake ECMO) With COVID-19 Adult Respiratory Distress Syndrome: The Israeli Experience. ASAIO J. 2023; 69(8):e363-e367. PMC: 10627399. DOI: 10.1097/MAT.0000000000001996. View

4.
Cho S, Geocadin R, Caturegli G, Chan V, White B, Dodd-O J . Understanding Characteristics of Acute Brain Injury in Adult Extracorporeal Membrane Oxygenation: An Autopsy Study. Crit Care Med. 2020; 48(6):e532-e536. DOI: 10.1097/CCM.0000000000004289. View

5.
Tipograf Y, Salna M, Minko E, Grogan E, Agerstrand C, Sonett J . Outcomes of Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation. Ann Thorac Surg. 2019; 107(5):1456-1463. DOI: 10.1016/j.athoracsur.2019.01.032. View